Abstract Immune checkpoint inhibitors (ICIs) are a standard treatment across cancers, yet most patients do not respond, and existing biomarkers generalize poorly across tumor types and therapies. Here we present COMPASS, a pan-cancer foundation model that predicts immunotherapy response from bulk tumor transcriptomes using a concept bottleneck transformer.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Daniel Marbach
Neoadjuvant PD-1 and LAG-3-targeting bispecific antibody and other immune checkpoint inhibitor combinations in resectable melanoma: the randomized phase 1b/2 Morpheus-Melanoma trial | Nature Medicine
Abstract Patients with stage III melanoma are at high risk of relapse. The NADINA trial evaluating neoadjuvant nivolumab plus ipilimumab and the SWOG-1801 trial evaluating neoadjuvant pembrolizumab have demonstrated superior clinical outcomes with neoadjuvant versus adjuvant checkpoint inhibition.
A microfluidic bone marrow chip for the safety profiling of biologics in pre-clinical drug development - Communications Biology
Abstract Hematologic adverse events are common dose-limiting toxicities in drug development. Classical animal models for preclinical safety assessment of immunotherapies are often limited due to insufficient cross-reactivity with non-human homologous proteins, immune system differences, and ethical considerations. Therefore, we evaluate a human bone marrow (BM) microphysiological system (MPS) for its ability to predict expected hematopoietic liabilities of immunotherapeutics.
Immune Modulation in Solid Tumors: A Phase 1b Study of RO6870810 (BET Inhibitor) and Atezolizumab (PD-L1 Inhibitor)
Authors1-5 are employees and/or shareholders of F Hoffmann-La Roche. All authors have received grants and non-financial or other support from F. Hoffmann-La Roche, during the conduct of the study. Editorial support, funded by the sponsor, was provided by an independent medical writer under the guidance of the authors. NCT03292172 This study was funded by F. Hoffmann-La Roche Ltd.
Contextual AI models for single-cell protein biology - Nature Methods
Abstract Understanding protein function and developing molecular therapies require deciphering the cell types in which proteins act as well as the interactions between proteins. However, modeling protein interactions across biological contexts remains challenging for existing algorithms. Here we introduce PINNACLE, a geometric deep learning approach that generates context-aware protein representations.
Async ist die Zukunft
Lesedauer 13 Min. Code zu async/await refaktorisieren Asynchroner Code bedarf besonderer Sorgfalt. Andernfalls läuft der Code im besten Fall einfach nicht asynchron oder das Programm glänzt durch besonders schwer zu findende Fehler. Deshalb bedarf auch das Umstellen auf Nebenläufigkeit besonderer Aufmerksamkeit.Dieser Artikel zeigt die Fallstricke bei diesem Prozess auf und wie Sie Stück für Stück Ihren Code auf async umstellen.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Daniel
Contact Daniel, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack